KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Income from Continuing Operations (2016 - 2025)

Abbott Laboratories' Income from Continuing Operations history spans 17 years, with the latest figure at 1776000000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 80.76% year-over-year to 1776000000.0; the TTM value through Dec 2025 reached 6524000000.0, down 51.32%, while the annual FY2025 figure was 6524000000.0, 51.32% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 1776000000.0 at Abbott Laboratories, up from 1644000000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 9229000000.0 in Q4 2024 and bottomed at 1033000000.0 in Q4 2022.
  • The 5-year median for Income from Continuing Operations is 1619000000.0 (2023), against an average of 1982650000.0.
  • The largest annual shift saw Income from Continuing Operations surged 478.98% in 2024 before it tumbled 80.76% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 1989000000.0 in 2021, then tumbled by 48.06% to 1033000000.0 in 2022, then surged by 54.31% to 1594000000.0 in 2023, then soared by 478.98% to 9229000000.0 in 2024, then crashed by 80.76% to 1776000000.0 in 2025.
  • Per Business Quant, the three most recent readings for ABT's Income from Continuing Operations are 1776000000.0 (Q4 2025), 1644000000.0 (Q3 2025), and 1779000000.0 (Q2 2025).